This announcement is a separate document:
德恒上海律师事务所关于天域生物科技股份有限公司2022年股票期权激励计划首次授予部分第二个行权期及预留授予部分第一个行权期行权条件未成就、注销部分已授予尚未行权的股票期权的法律意见书
Legal Opinion of Deheng Shanghai Law Firm on Tianyu Biotechnology Co., Ltd.\'s 2022 Stock Options Incentive Plan for the first time granting part of the second exercise period and reserving the granting of part of the first exercise period, unfulfilled exercise conditions, and cancellation of some stock options granted that have not yet been exercised
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated